SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: VLAD who wrote (20854)4/20/1999 12:16:00 PM
From: Brent  Read Replies (2) of 23519
 
VLAD,

<Yes product sales for Q1 will suck but considering that nobody is marketing it in the USA and Europe still has not been launched what do you expect? >

The product sales are what I expected and I do believe Vivus has alot of potential. When we sign a domestic partner and Astra gets sales going in Europe, things will improve dramatically.

All I am saying is the shorts aren't the enemy. It is not a conspiracy to destroy Vivus. They just don't think Muse will ever sell enough to make Vivus a viable company. And there opinion is ok with me. If they are right, at least someone makes money off my mistake. If they are wrong, they will be more fuel for the rocketship taking off.

My point is that blaming the shorts for Vivus' failure is like blaming the other person when you lose a bet. We are betting on the outcome of Vivus as a company, we think Vivus will be a viable company the shorts don't.

Brent
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext